The HIP Self-management Study

Summary

The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT).

The main purpose of the study is:

1. To investigate the clinical effectiveness of a self- management program versus usual care for patients with greater trochanteric pain syndrome (GTPS).

* H0: There is no difference between a self-management program and usual care on pain and function in patients with GTPS.
* H1: There is a difference between a self-management program and usual care on pain and function in patients with GTPS.
2. To investigate if self-management is more cost-effective than usual care in the treatment of patients with GTPS.

Participants will be randomly allocated into one of two groups: 1) self-management program or 2) usual care.

Follow-up will be at 3-, 6- and 12-months.

Conditions

• GTPS - Greater Trochanteric Pain Syndrome
• Gluteal Tendinopathy
• Trochanteric Bursitis
• Lateral Hip Pain

Interventions

OTHER

Self-management

Patients will have 3-5 sessions with a physiotherapist that include individually tailored education, and address physical, cognitive, and behavioral factors deemed as relevant according to the participant's concerns and challenges. Important aspects in this are: problem-solving, decision-making, resource utilization, therapeutic alliance and taking action (The 5 core skills of self-management). SMART goals and an activity plan between sessions will be used as an exposure to maintain, change, or create health behavior. Participants will have access to study material, including exercise alternatives and a podcast.

OTHER

Usual care

Usual care at the department consists of general information about the condition and advice on pain management and exercise. For further treatment, patients are referred to primary care. Participation in the study will not affect how this is conducted.

Sponsors & Collaborators

• Oslo Metropolitan University

  collaborator OTHER

• Fysiofondet

  collaborator OTHER

• University of Oslo

  collaborator OTHER

• Oslo University Hospital

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-03-12

Primary Completion

2026-07-31

Completion

2026-10-31

Countries

• Norway

Study Locations